Prognosis
Glaxo Wants to Look Inside Your Gut to Discover New Vaccines
- Drugmaker signs two-year agreement with Benioff-backed Viome
- Microbiome science is next frontier for many drug developers
Photographer: Kateryna Kon/Science Photo Library
This article is for subscribers only.
GlaxoSmithKline Plc is exploring the trillions of microbes that inhabit the gut in pursuit of novel ways to prevent some of the world’s most common ailments.
The U.K. pharma giant is teaming up with Viome, a company backed by venture capitalist Vinod Khosla and Salesforce.com Inc. co-founder Marc Benioff, to gain a deeper understanding of the universe of bacteria that dwell in the digestive tract and the role they play in the body’s immune system.